Search Results - "Bernardo, Maria Ester"

Refine Results
  1. 1

    How I treat relapsed childhood acute lymphoblastic leukemia by Locatelli, Franco, Schrappe, Martin, Bernardo, Maria Ester, Rutella, Sergio

    Published in Blood (04-10-2012)
    “…The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains relapse, occurring in ∼ 15%-20% of patients. Survival of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation by Bernardo, Maria Ester, Fibbe, Willem E.

    Published in Cell stem cell (03-10-2013)
    “…In addition to their stem/progenitor properties, mesenchymal stromal cells (MSCs) possess broad immunoregulatory properties that are being investigated for…”
    Get full text
    Journal Article
  5. 5

    Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation by Crippa, Stefania, Bernardo, Maria Ester

    Published in HemaSphere (01-12-2018)
    “…Mesenchymal stromal cells (MSCs) are key elements in the bone marrow (BM) niche where they interact with hematopoietic stem progenitor cells (HSPCs) by…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders by Bernardo, Maria Ester, Fibbe, Willem E.

    Published in Annals of the New York Academy of Sciences (01-08-2012)
    “…Mesenchymal stromal cells (MSCs) are being employed in clinical trials to facilitate engraftment and to treat steroid‐resistant acute graft‐versus‐host disease…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I by Penati, Rachele, Fumagalli, Francesca, Calbi, Valeria, Bernardo, Maria Ester, Aiuti, Alessandro

    Published in Journal of inherited metabolic disease (01-07-2017)
    “…Lysosomal storage diseases (LSDs) are rare inherited metabolic disorders characterized by a dysfunction in lysosomes, leading to waste material accumulation…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    MPSI Manifestations and Treatment Outcome: Skeletal Focus by De Ponti, Giada, Donsante, Samantha, Frigeni, Marta, Pievani, Alice, Corsi, Alessandro, Bernardo, Maria Ester, Riminucci, Mara, Serafini, Marta

    “…Mucopolysaccharidosis type I (MPSI) (OMIM #252800) is an autosomal recessive disorder caused by pathogenic variants in the IDUA gene encoding for the lysosomal…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches by Fraldi, Alessandro, Serafini, Marta, Sorrentino, Nicolina Cristina, Gentner, Bernhard, Aiuti, Alessandro, Bernardo, Maria Ester

    Published in Italian journal of pediatrics (16-11-2018)
    “…Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a deficiency in lysosomal enzymes catalyzing the stepwise degradation of…”
    Get full text
    Journal Article
  20. 20